Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cb16f3933087407282046d3265c0c4e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
filingDate |
2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_081bc957ead6e86e841bbdecd709b725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79285689c8ca839ebb27fb4f13325deb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fff529b12c09910c4d6d55001fe42621 |
publicationDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7943317-B2 |
titleOfInvention |
Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment |
abstract |
This invention relates to nucleotide polymorphisms in the human Apo(a) gene and to the use of Apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017335394-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020248262-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014024623-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10550433-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011206667-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015284799-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11697850-B2 |
priorityDate |
2007-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |